About Theratome Bio
Theratome Bio is a private company based in Houston, Texas. It has reported $1,918,500 raised in two offerings on Form D since April 2016.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Sep 14, 2023 | Sep 21, 2023 | $28,500of $950K target | 1 | $28,500 | Equity, Options, Securities on exerciseRule 506(c) | Form D ↗ |
| Feb 3, 2016 | Apr 4, 2016 | $1,890,000of $3.5M target | 6 | $315K | EquityRule 506(b) | Form D ↗ |
| Total, two offerings | $1,918,500 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Theratome Bio's Form D filed Sep 21, 2023.
MR
Michael Redman
Executive officer and director
KP
Keith March MD PhD
Executive officer and director
BM
Brad Miller
Director
JP
James Payne
Executive officer
MT
Michael Trotta
Director
Earlier filings also listed Wade Lange (president, last listed Apr 2016), Scott Jones (director, last listed Apr 2016), Keith March (director, last listed Apr 2016) and Jennifer Rhodes (executive officer, last listed Apr 2016).